SMR Stemless
LimaCorporate’s SMR Stemless is a bone Sparing Implant based on our established SMR heritage. It also features a TT proximal ring.
Please note that not all products are available and registered in every market: contact your LimaCorporate Sales Representative for any further information.
Benefits
01
Real Versatility
SMR Stemless allows orthopedic surgeons to perform anatomic, reverse or CTA Head prosthesis using reduced instrumentation.
02
Anatomical Reconstruction
The SMR Stemless Cores and adaptors offer the possibility to choose the most appropriate solution for each patient´s individual anatomy.
03
TT Reliable Fixation
SMR Stemless has been designed to achieve strong primary fixation and favor osteointegration.
Images
About
LimaCorporate’s SMR Stemless Cores are a universal inlay component, designed to provide the optimal solution for a wide range of pathologies.
Real Versatility enables orthopedic surgeons to offer adequate bone sparing solutions to a large patient population according to each individual patient’s needs.
The wide range of sizes and humeral head adapters facilitate anatomic reconstruction, helping to restore the original humeral head. SMR Stemless Cores´ geometry respect the morphology of the proximal humeral bone, finding fixation in its strongest parts. The cores have shown a positive effect on bone mass and bone density after component implantation [1,3,4].
The use of LimaCorporate’s patent technology, Trabecular Titanium, in the proximal ring aims to improve stability and tissue ingrowth. The material, the structure, the mechanical properties, and the enhanced initial fixation are the premises for an initial primary fixation followed by the biologic integration of the implants [5-8]. SMR Stemless is based on the successful clinical heritage of the SMR System and is compatible with all its glenoid components.
See bibliography
Bibliography
[1] Commenda M, Quental C, Folgado J, Sarmento M, Montiero J. Bone adaptation impact of stemless shoulder implants: a computational analysis. J Shoulder Elbow Surg (2019) -, 1–11
[2] Dorleijn D, et al. Short-term results of total shoulder arthroplasty for ochronotic arthritis. Journal of Surgical Case Reports, 2019;7, 1–4
[3] Churchill RS, Athwal GS. Stemless shoulder arthroplasty-current results and designs. Curr Rev Musculoskelet Med. 2016 Mar;9(1):10-6.
[4] Reeves JM, Athwal GS, Johnson JA. An assessment of proximal humerus density with reference to stemless implants J Shoulder Elbow Surg 2018 Apr; 27(4): 641-9.
[5] * E. Marin, L. Fedrizzi, M. Regis, M. Pressacco, L. Zagra, S. Fusi. Stability enhancement of prosthetic implants: friction analysis of Trabecular
TitaniumTM. Hip International, 22(4): 427-428, 2012.
[6] * V. Sollazzo, A. Palmieri, L. Massari, F. Carinci. Genetic effects of Trabecular TitaniumTM on cells MG-63 cell line: an in vitro study. J Orthpaed
Traumatol., 13(1): 107, 2012.
[7] * Benazzo F, Botta L, Scaffino MF, Caliogna L, Marullo M, Fusi S, Gastaldi G. Trabecular Titanium can induce in vitro osteogenic differentiation of
human adipose derived stem cells without osteogenic factors. J Biomed Mater Res Part A. 2014:102A:2061–71.
[8] * Devine D, Arens D, Burelli S, Bloch HR, Boure L. In vivo evaluation of the osteointegration of new highly porous Trabecular Titanium™. J Bone
Joint Surg Br. 2012;94-B(Suppl XXXVII):201.
[9] . LimaCorporate Internal Report. A multicentre, prospective clinical study analysing outcomes of shoulder arthroplasty with SMR Stemless. Ad Interim Radiographical Analysis Report. December 2018.
*Results from clinical studies.
[1] Commenda M, Quental C, Folgado J, Sarmento M, Montiero J. Bone adaptation impact of stemless shoulder implants: a computational analysis. J Shoulder Elbow Surg (2019) -, 1–11
[2] Dorleijn D, et al. Short-term results of total shoulder arthroplasty for ochronotic arthritis. Journal of Surgical Case Reports, 2019;7, 1–4
[3] Churchill RS, Athwal GS. Stemless shoulder arthroplasty-current results and designs. Curr Rev Musculoskelet Med. 2016 Mar;9(1):10-6.
[4] Reeves JM, Athwal GS, Johnson JA. An assessment of proximal humerus density with reference to stemless implants J Shoulder Elbow Surg 2018 Apr; 27(4): 641-9.
[5] * E. Marin, L. Fedrizzi, M. Regis, M. Pressacco, L. Zagra, S. Fusi. Stability enhancement of prosthetic implants: friction analysis of Trabecular
TitaniumTM. Hip International, 22(4): 427-428, 2012.
[6] * V. Sollazzo, A. Palmieri, L. Massari, F. Carinci. Genetic effects of Trabecular TitaniumTM on cells MG-63 cell line: an in vitro study. J Orthpaed
Traumatol., 13(1): 107, 2012.
[7] * Benazzo F, Botta L, Scaffino MF, Caliogna L, Marullo M, Fusi S, Gastaldi G. Trabecular Titanium can induce in vitro osteogenic differentiation of
human adipose derived stem cells without osteogenic factors. J Biomed Mater Res Part A. 2014:102A:2061–71.
[8] * Devine D, Arens D, Burelli S, Bloch HR, Boure L. In vivo evaluation of the osteointegration of new highly porous Trabecular Titanium™. J Bone
Joint Surg Br. 2012;94-B(Suppl XXXVII):201.
[9] . LimaCorporate Internal Report. A multicentre, prospective clinical study analysing outcomes of shoulder arthroplasty with SMR Stemless. Ad Interim Radiographical Analysis Report. December 2018.
*Results from clinical studies.
Sizing
& Options
SMR Stemless The SMR Stemless Cores range offer orthopedic surgeons the possibility to choose the most appropriate solution for a patients’ anatomy.
Papers
Resources
Related Products
Disclaimer
Please note that not all products are available and registered in every market. Please contact your LimaCorporate Sales Representative for any further information.
LPSI, SpaceFlex e SYMBOL® are distributed by Limacorporate S.p.A.
BIOLOX® / BIOLOX®delta / BIOLOX OPTION® is a registered trademark of a company of the CeramTec Group, Germany.
LPSI, SpaceFlex e SYMBOL® are distributed by Limacorporate S.p.A.
BIOLOX® / BIOLOX®delta / BIOLOX OPTION® is a registered trademark of a company of the CeramTec Group, Germany.